Adaptation of lot quality assurance sampling to monitor seasonal malaria chemoprevention delivery performance

Trans R Soc Trop Med Hyg. 2024 Oct 1;118(10):642-645. doi: 10.1093/trstmh/trae051.

Abstract

Malaria Consortium supports delivery of seasonal malaria chemoprevention (SMC) to children ages 3-59 months using sulfadoxine-pyrimethamine plus amodiaquine. Lot quality assurance sampling (LQAS) was adapted as a cost-efficient method for end-of-cycle SMC monitoring surveys across supported countries and an implementation challenges reporting system was established in Nigeria. We present a case study of its application in Nasarawa State. LQAS facilitated timely local performance assessment across 16 indicators. Development of new reporting tools has played a key role in stimulating national-level discussions on improvements to SMC supervisory processes and implementer training and provided a framework for engagement with local stakeholders.

Keywords: healthcare quality assessments; lot quality assurance sampling; malaria; prevention and control.

MeSH terms

  • Amodiaquine* / therapeutic use
  • Antimalarials* / therapeutic use
  • Chemoprevention* / standards
  • Child, Preschool
  • Drug Combinations*
  • Female
  • Humans
  • Infant
  • Lot Quality Assurance Sampling*
  • Malaria* / prevention & control
  • Nigeria
  • Pyrimethamine* / therapeutic use
  • Seasons*
  • Sulfadoxine* / therapeutic use

Substances

  • Antimalarials
  • Pyrimethamine
  • Sulfadoxine
  • fanasil, pyrimethamine drug combination
  • Amodiaquine
  • Drug Combinations

Grants and funding